<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="format-detection" content="telephone=no">
<title>More Than 24 Months for Patients With High Fracture Risk|EDM#5</title>
<style>
html{
    background:#F8F6F5}
body{
    width: 100%;
	margin:0;
	padding:0;
    font-family:'Microsoft JhengHei','PingFangTC-Regular', 'Arial', 'Helvetica', sans-serif}
image{
	border:0}
</style>
</head>


<body>
    <table width="640" cellspacing="0" cellpadding="0" style="margin: 0 auto; background-color: #eee">
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_01.png" width="640" height="171" style="display:block;outline:0;border:0" alt="More Than 24 Months for Patients With High Fracture Risk">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_02.png" width="640" height="91" style="display:block;outline:0;border:0" alt="What's new">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_03.png" width="640" height="123" style="display:block;outline:0;border:0" alt="* In Nov 2020, FDA relieved the restriction of treatment duration of Forteo, which was 24 months within a person's lifetime. * At the end of Oct 2021, TFDA also loose this restriction: removing the warning box of osteosarcoma and the restriction of 24 months within a patient's lifetime.?">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_04.png" width="640" height="91" style="display:block;outline:0;border:0" alt="Why relieved? Gilsenan et al. demonstrated that Forteo did not increase the osteosarco ma incidence in a 15-year US post-marketing surveillance study.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_05.png" width="640" height="119" style="display:block;outline:0;border:0" alt="What did the study say? In this study, a standardized incidence ratio was estimated to compare the observed and expected numbers of osteosarcoma patients with a prior history of Forteo treatment.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_06.png" width="640" height="143" style="display:block;outline:0;border:0" alt="* Based On the background incidence rate, the expected number of osteosarcoma cases among patients treated with Forteo was 4.17, while the observed cases number which were related to Forteo was only 3. * This result indicated the standardized incidence ratio was 0.72(90% CI=0.2 to 1.86), leading to the conclusion that Forteo did not increase adult osteosarcoma incidence.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_07.png" width="640" height="138" style="display:block;outline:0;border:0" alt="Conclusion: Therefore, prescription information of Forteo has been revised, and the restriction of 24 months treatment duration within lifetime also has been relieved for patients who have a high risk for fracture.">
            </td>
        </tr>
        <tr>
            <td>
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988650/" title="riskcheck.osteoporosis.foundation" target="_blank"> 
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_08.png" width="640" height="53" style="display:block;outline:0;border:0" alt="Find more information">
                </a>
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-05_09.png" width="640" height="110" style="display:block;outline:0;border:0" alt="copyright">
            </td>
        </tr>
    </table>
</body>
</html>